Physician
Infectious Disease
Dr. Alison E. Heald, MD
|
|
Give Review
Alison E. Heald practices Infectious Disease. She went to Perelman School of Medicine at the University of Pennsylvania. Alison Heald is also published. She has 38 publications published. The lastest publication: "Taste and smell complaints in HIV-infected patients.' She accepts Medicare.
Publications
- Stroke in a Patient With Human Immunodeficiency Virus and Syphilis Treated With Penicillin and Antiretroviral Therapy.
- A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virus.
- A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine.
- Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial.
- Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a mult...
- Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: ...
- A multicenter phase II study of tgDCC-E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinoma.
- HIV infection: treatment outcomes in older and younger adults.
- Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study.
- Physical health in schizophrenia: a challenge for antipsychotic therapy.
- Management of physical health in patients with schizophrenia: practical recommendations.
- Inflammatory markers and growth in South Asian and European origin infants in Britain: the Manchester Children''s Growth and Vascular Health Study.
- On the use of low-cost computer peripherals for the assessment of motor dysfunction in Parkinson's disease--quantification of bradykinesia using target tracking tasks.
- A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l.
- Brain biopsy for HIV-infected patients with intracranial lesions.
- Taste and smell. Neglected senses that contribute to the malnutrition of AIDS.
- Clinical complications of HIV infection.
- Effect of protease inhibitors on the sense of taste.
- Cryptosporidium spread in a group residential home.
- Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus.
- Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis...
- Effect of antimicrobial and anti-inflammatory medications on the sense of taste.
- Characteristics of individuals infected with the human immunodeficiency virus and provider interaction in the predominantly rural Southeast.
- Effect of the nucleoside analogs zidovudine, didanosine, stavudine, and lamivudine on the sense of taste.
- Taste and smell losses in HIV infected patients.
- Taste and smell complaints in HIV-infected patients.
- Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET).
- Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, pl...
- Association of plasma levels of human immunodeficiency virus type 1 RNA and oropharyngeal Candida colonization.
- Assessing single joints in arthritis clinical trials.
- Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapy.
- Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction.
- Protease inhibitors are associated with a slowed progression of HIV-related renal diseases.
- Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation s...
- Evaluation of exposure and health care worker response to nebulized administration of tgAAVCF to patients with cystic fibrosis.
- Single-joint outcome measures: preliminary validation of patient-reported outcomes and physical examination.
- Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene:...
Schools
Univ Of Pa Sch Of Med
Yale New Haven Hospital
Duke University Med Center
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Duke University Hospital -
Yale-New Haven Hospital -
Perelman School of Medicine at the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1467671222 | |
| NPPES Provider LastName | HEALD | |
| NPPES Provider FirstName | ALISON | |
| NPPES Provider ZIPCode | 981042499 | |
| NPPES Provider State | WA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 542.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467671222 |
| Last Name Of The Provider | HEALD |
| First Name Of The Provider | ALISON |
| View All |
Similar Doctors
|
|
Dr. Michael R. Cairns, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Justin S. Jin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Reena K. Gulati, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Taylor G. Sandison, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ruanne V. Barnabas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jo Hofmann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura A. Quilter, MD |
|
|
Dr. Christina S. Polyak, MD
This Doctor is OpenDoctor Recommended.
|